Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Frontzek, F., Ziepert, M., Nickelsen, M., Altmann, B., Glass, B., Haenel, M., Truemper, L., Held, G., Bentz, M., Borchmann, P., Dreyling, M., Viardot, A., Kroschinsky, F., Metzner, B., Staiger, A. M., Horn, H., Ott, G., Rosenwald, A., Loeffler, M., Lenz, G. and Schmitz, N. (2020). 10-year follow-up of the R-MegaCHOEP trial: conditional survival analysis reveals 1-year progression-free survival as crucial prognostic factor for long-term outcome in young high-risk patients with aggressive B-cell lymphoma. Oncol. Res. Treat., 43 (SUPPL 4). S. 64 - 65. BASEL: KARGER. ISSN 2296-5262

Giannotti, F., Labopin, M., Ruggeri, A., Ehninger, G., Niederwieser, D., Stelljes, M., Stuhler, G., Kroeger, N., Einsele, H., Eder, M., Hallek, M., Glass, B., Finke, J., Ciceri, F., Mohty, M. and Nagler, A. (2017). Outcomes after matched unrelated donor and non-T-cell depleted haploidentical stem cell transplantation in patients >= 60 years with acute myeloid leukemia: A comparative study on behalf of the ALWP of the EBMT. Bone Marrow Transplant., 52. S. S36 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Glass, B., Ziepert, M., Reiser, M., Freund, M., Truemper, L., Metzner, B., Feller, A., Loeffler, M., Pfreundschuh, M. and Schmitz, N. (2010). High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. Ann. Oncol., 21 (11). S. 2255 - 2262. OXFORD: OXFORD UNIV PRESS. ISSN 0923-7534

Huebel, K., Ostermann, H., Noppeney, R., Glass, B., Berger, K., Reitan, J. and Mohty, M. (2015). Quantification of the time and effort associated with autologous peripheral blood stem cell mobilisation: A European perspective. Oncol. Res. Treat., 38. S. 72 - 73. BASEL: KARGER. ISSN 2296-5262

Mohty, M., Azar, N., Chabannon, C., LGouill, S., Karlin, L., Farina, L., Ostermann, H., Glass, B., Noppeney, R. and Huebel, K. (2017). Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis. Bone Marrow Transplant., 52. S. S19 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

This list was generated on Thu Mar 28 23:34:38 2024 CET.